T1	Intervention 139 159	amlodipine camsylate
T2	Intervention 167 186	amlodipine besylate
T3	Intervention 252 271	Amlodipine besylate
T4	Intervention 393 413	Amlodipine camsylate
T5	Intervention 740 760	amlodipine camsylate
T6	Intervention 765 784	amlodipine besylate
T7	Intervention 896 916	amlodipine camsylate
T8	Intervention 931 950	amlodipine besylate
T9	Intervention 1439 1532	randomly assigned to receive oral treatment with amlodipine camsylate or amlodipine besylate.
T10	Intervention 1533 1603	For the first 4 weeks, patients received amlodipine 5 mg QD (morning).
T11	Intervention 1604 1795	After 4 weeks, if either blood pressure was > or =140/ > or =90 mm Hg or SiDBP had not decreased by > or =10 mm Hg from baseline, the dose of amlodipine was increased to 10 mg QD for 4 weeks.
T12	Intervention 1796 2015	Trough blood pressure and heart rate were measured in duplicate with the patient in the sitting position at each clinic visit (baseline [week 0] and weeks 4 and 8 of treatment); mean values were calculated and recorded.
T13	Intervention 2016 2152	At weeks 4 and 8, tolerability was assessed using history taking and laboratory analysis, and compliance was assessed using pill counts.
T14	Intervention 2590 2610	amlodipine camsylate
T15	Intervention 2966 2986	amlodipine camsylate
T16	Intervention 2999 3019	amlodipine besylate)
T17	Intervention 3040 3060	amlodipine camsylate
T18	Intervention 3090 3109	amlodipine besylate
T19	Intervention 3288 3309	(amlodipine camsylate
T20	Intervention 3392 3411	amlodipine besylate
T21	Intervention 3878 3899	(amlodipine camsylate
T22	Intervention 3909 3928	amlodipine besylate
T23	Intervention 4044 4064	amlodipine camsylate
T24	Intervention 4069 4088	amlodipine besylate
T25	Intervention 4154 4174	amlodipine camsylate
T26	Intervention 4222 4241	amlodipine besylate
